Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:27:04 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:AMGN - AMGEN INC - http://www.amgen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AMGN - Q0.1269.00·294.260.1269.98+0.600.22,437.0656,38030,621265.72  271.68  265.72329.72  211.7118:58:5709:0015 min RT 2¢

Recent Trades - Last 10 of 30621
Time ETExPriceChangeVolume
18:58:57Q268.90-0.485
17:30:23Q269.10-0.2818
17:12:42Q269.02-0.361
16:18:57Q269.980.601
16:15:04Q269.980.601
16:15:04Q269.980.601
16:08:39Q268.00-1.3812
16:06:38Q269.980.60125
16:03:08Q269.840.465
16:03:07Q269.880.5010

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-26 09:00U:AMGNNews ReleaseAMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
2024-04-16 17:26U:AMGNNews ReleaseAMGEN TO PRESENT TEZSPIRE(TM) PHASE 2A COPD DATA AT ATS 2024
2024-03-09 12:20U:AMGNNews ReleaseAMGEN PRESENTS NEW RESEARCH ON OTEZLA(TM) (APREMILAST) AT AAD 2024
2024-03-06 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
2024-02-29 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
2024-02-26 09:00U:AMGNNews ReleaseAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
2024-02-19 16:00U:AMGNNews ReleaseAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
2024-02-09 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
2024-02-06 16:01U:AMGNNews ReleaseAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
2024-02-01 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
2024-01-29 05:00U:AMGNNews ReleasedeCODE genetics: A sequence variant that increases risk of pregnancy loss
2024-01-09 10:25U:AMGNNews ReleaseGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
2024-01-03 16:00U:AMGNNews ReleaseAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
2023-12-26 09:00U:AMGNNews ReleaseAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS ‚ ® (SOTORASIB)
2023-12-14 09:00U:AMGNNews ReleaseAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION
2023-12-14 05:00U:AMGNNews ReleaseAMGEN TO SPONSOR THE IRISH OPEN
2023-12-13 16:00U:AMGNNews ReleaseFDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
2023-12-12 16:00U:AMGNNews ReleaseAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
2023-12-08 09:00U:AMGNNews ReleaseAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023